JPRN-UMIN000015185已完成未知
Clinical efficacy of levocarnitine supplementation in patients with hemodialysis - Levocarnitine on hemodialysis patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) history of amputation of extremities or the presence of peripheral arterial disease; (2) a history of severe heart failure, angina, myocardial infarction, or stroke within the past 6 months; (3) the presence of infectious disease, thyroid disease, malignant tumors, or treatment with steroids or immunosuppressants; and (4) L-carnitine supplementation within the past 6 months.
研究者
相似试验
已完成
不适用
Efficacy of levocarnitine as an add-on treatment to branched-chain amino acid-enriched nutritional supplementation on liver cirrhosis complicated by hepatic encephalopathy -a open-label studyiver cirrhosisJPRN-UMIN000012096Faculty of Medical Sciences, University of Fukui40
已完成
不适用
Safety and efficacy of L-carnitine supplementation in patients with hematopoietic stem cell transplantatioHematological malignancy, Bone marrow failure syndromeJPRN-UMIN000012424Sapporo Medical University School of Medicine, Department of Medical Oncology and Hematology30
已完成
不适用
Investigation of efficacy of levocarnitine intravenous formulation in patients undergoing hemodialysisJPRN-UMIN000035143Ministry of Education, Culture, Sports, Science and Technology96
招募中
3 期
Effect of L-carnitine in Ischemic StrokeIschemic stroke.Cerebral infarctionIRCT20221206056734N1Ahvaz University of Medical Sciences82
已完成
不适用
Prevalence rate of carnitine and zinc deficiency and the efficacy of levocarnitine injection therapy in dialysis patients with renal anemiaEnd-stage kidney disease undergoing hemodialysis or peritoneal dialysis with renal anemia.JPRN-UMIN000025327ihon University School of Medicine90